Search research articles
Contact Us
Filters
Showing results (41-50 of 94) with videos related to
Page
of 10
Sort By:
Blood Neoplasia
|
May 7, 2026
Impact of baseline osseous involvement on outcomes in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia
John Sharp, Subodh Bhatta, Noah Takacs, et al.
Cancer Medicine
|
March 17, 2017
The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia
Daphne Guinn, Amy Lehman, Catherine Fabian, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 23, 2025
Resistance Mechanism for Zanubrutinib in Marginal Zone Lymphoma
John Sharp, Arwa Y Shana'ah, Timothy J Voorhees, et al.
Mabs
|
March 6, 2014
Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia
Carolyn M Cheney, Deborah M Stephens, Xiaokui Mo, et al.
Blood
|
January 30, 2019
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma
Peter Martin, Nancy L Bartlett, Kristie A Blum, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 10, 2026
Longitudinal plasma neurofilament light chain and patient-reported outcomes as complementary markers of vincristine-associated peripheral neuropathy in adults with lymphoma: a cohort study
Gretchen A McNally, Grace Ji-Eun Shin, Lise Worthen-Chaudhari, et al.
Journal of Hematology & Oncology
|
January 5, 2025
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma
Sayan Mullick Chowdhury, Subodh Bhatta, Timothy J Voorhees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2022
Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts
Peter Martin, Jonathon B Cohen, Michael Wang, et al.
Journal of the National Cancer Institute
|
January 2, 2017
Recommendations for Clinical Trial Development in Follicular Lymphoma
Kami Maddocks, Paul M Barr, Bruce D Cheson, et al.
British Journal of Haematology
|
October 4, 2007
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia
Kami Maddocks-Christianson, Susan L Slager, Clive S Zent, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 94) with videos related to
Sort By:
Page
of 10
Blood Neoplasia
|
May 7, 2026
Impact of baseline osseous involvement on outcomes in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia
John Sharp, Subodh Bhatta, Noah Takacs, et al.
Cancer Medicine
|
March 17, 2017
The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia
Daphne Guinn, Amy Lehman, Catherine Fabian, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 23, 2025
Resistance Mechanism for Zanubrutinib in Marginal Zone Lymphoma
John Sharp, Arwa Y Shana'ah, Timothy J Voorhees, et al.
Mabs
|
March 6, 2014
Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia
Carolyn M Cheney, Deborah M Stephens, Xiaokui Mo, et al.
Blood
|
January 30, 2019
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma
Peter Martin, Nancy L Bartlett, Kristie A Blum, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 10, 2026
Longitudinal plasma neurofilament light chain and patient-reported outcomes as complementary markers of vincristine-associated peripheral neuropathy in adults with lymphoma: a cohort study
Gretchen A McNally, Grace Ji-Eun Shin, Lise Worthen-Chaudhari, et al.
Journal of Hematology & Oncology
|
January 5, 2025
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma
Sayan Mullick Chowdhury, Subodh Bhatta, Timothy J Voorhees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2022
Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts
Peter Martin, Jonathon B Cohen, Michael Wang, et al.
Journal of the National Cancer Institute
|
January 2, 2017
Recommendations for Clinical Trial Development in Follicular Lymphoma
Kami Maddocks, Paul M Barr, Bruce D Cheson, et al.
British Journal of Haematology
|
October 4, 2007
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia
Kami Maddocks-Christianson, Susan L Slager, Clive S Zent, et al.
Page
of 10